Pacific Health Care Organization Competitors

Caladrius Biosciences (NASDAQ:CLBS) and Pacific Health Care Organization (OTCMKTS:PFHOD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Caladrius Biosciences and Pacific Health Care Organization, as provided by MarketBeat.com.

Caladrius Biosciences presently has a consensus target price of $10.00, indicating a potential upside of 553.59%. Given Caladrius Biosciences' higher probable upside, equities analysts clearly believe Caladrius Biosciences is more favorable than Pacific Health Care Organization.

Earnings & Valuation

This table compares Caladrius Biosciences and Pacific Health Care Organization's gross revenue, earnings per share (EPS) and valuation.

Pacific Health Care Organization has higher revenue and earnings than Caladrius Biosciences.

Risk and Volatility

Caladrius Biosciences has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Pacific Health Care Organization has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.

Profitability

This table compares Caladrius Biosciences and Pacific Health Care Organization's net margins, return on equity and return on assets.

Institutional and Insider Ownership

9.0% of Caladrius Biosciences shares are held by institutional investors. 10.3% of Caladrius Biosciences shares are held by insiders. Comparatively, 61.6% of Pacific Health Care Organization shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Pacific Health Care Organization beats Caladrius Biosciences on 6 of the 10 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHOD) and Baudax Bio (NASDAQ:BXRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current recommendations for Pacific Health Care Organization and Baudax Bio, as provided by MarketBeat.com.

Baudax Bio has a consensus target price of $13.50, indicating a potential upside of 1,161.68%. Given Baudax Bio's higher probable upside, analysts plainly believe Baudax Bio is more favorable than Pacific Health Care Organization.

Earnings and Valuation

This table compares Pacific Health Care Organization and Baudax Bio's gross revenue, earnings per share and valuation.

Pacific Health Care Organization has higher revenue and earnings than Baudax Bio.

Volatility and Risk

Pacific Health Care Organization has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Baudax Bio has a beta of 2.56, meaning that its stock price is 156% more volatile than the S&P 500.

Profitability

This table compares Pacific Health Care Organization and Baudax Bio's net margins, return on equity and return on assets.

Institutional & Insider Ownership

7.9% of Baudax Bio shares are held by institutional investors. 61.6% of Pacific Health Care Organization shares are held by company insiders. Comparatively, 13.1% of Baudax Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pacific Health Care Organization beats Baudax Bio on 6 of the 10 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHOD) and Cryo-Cell International (OTCMKTS:CCEL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current recommendations for Pacific Health Care Organization and Cryo-Cell International, as provided by MarketBeat.com.

Earnings and Valuation

This table compares Pacific Health Care Organization and Cryo-Cell International's gross revenue, earnings per share and valuation.

Cryo-Cell International has higher revenue and earnings than Pacific Health Care Organization.

Volatility and Risk

Pacific Health Care Organization has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Cryo-Cell International has a beta of 0.29, meaning that its stock price is 71% less volatile than the S&P 500.

Profitability

This table compares Pacific Health Care Organization and Cryo-Cell International's net margins, return on equity and return on assets.

Institutional & Insider Ownership

1.0% of Cryo-Cell International shares are held by institutional investors. 61.6% of Pacific Health Care Organization shares are held by company insiders. Comparatively, 53.8% of Cryo-Cell International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pacific Health Care Organization beats Cryo-Cell International on 6 of the 9 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHOD) and GreenVision Acquisition (NASDAQ:GRNV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current recommendations for Pacific Health Care Organization and GreenVision Acquisition, as provided by MarketBeat.com.

Earnings and Valuation

This table compares Pacific Health Care Organization and GreenVision Acquisition's gross revenue, earnings per share and valuation.

Pacific Health Care Organization has higher revenue and earnings than GreenVision Acquisition.

Profitability

This table compares Pacific Health Care Organization and GreenVision Acquisition's net margins, return on equity and return on assets.

Institutional & Insider Ownership

67.7% of GreenVision Acquisition shares are held by institutional investors. 61.6% of Pacific Health Care Organization shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pacific Health Care Organization beats GreenVision Acquisition on 5 of the 6 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHOD) and Emmaus Life Sciences (OTCMKTS:EMMA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current recommendations for Pacific Health Care Organization and Emmaus Life Sciences, as provided by MarketBeat.com.

Earnings and Valuation

This table compares Pacific Health Care Organization and Emmaus Life Sciences' gross revenue, earnings per share and valuation.

Pacific Health Care Organization has higher revenue and earnings than Emmaus Life Sciences.

Volatility and Risk

Pacific Health Care Organization has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Emmaus Life Sciences has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500.

Profitability

This table compares Pacific Health Care Organization and Emmaus Life Sciences' net margins, return on equity and return on assets.

Institutional & Insider Ownership

0.1% of Emmaus Life Sciences shares are held by institutional investors. 61.6% of Pacific Health Care Organization shares are held by company insiders. Comparatively, 36.9% of Emmaus Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pacific Health Care Organization beats Emmaus Life Sciences on 6 of the 9 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHOD) and Curative Biotechnology (OTCMKTS:CTYX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Earnings and Valuation

This table compares Pacific Health Care Organization and Curative Biotechnology's gross revenue, earnings per share and valuation.

Pacific Health Care Organization has higher revenue and earnings than Curative Biotechnology.

Profitability

This table compares Pacific Health Care Organization and Curative Biotechnology's net margins, return on equity and return on assets.

Volatility & Risk

Pacific Health Care Organization has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Curative Biotechnology has a beta of -31.94, indicating that its stock price is 3,294% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Pacific Health Care Organization and Curative Biotechnology, as provided by MarketBeat.com.

Summary

Pacific Health Care Organization beats Curative Biotechnology on 5 of the 5 factors compared between the two stocks.